Kestra Medical Technologies, Ltd. Common Stock KMTS Ratios & Valuation
| TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 48.8%+2.4pp | 46.4%+2.9pp | 43.5%+3.0pp | 40.5%+6.8pp | |
| Operating margin | -171.5%+2.8pp | -174.3%+1.6pp | -175.9%+1.9pp | -177.8%-17.5pp | |
| Net margin | -173%+5.0pp | -178%+2.4pp | -180.3%+9.9pp | -190.3%-18.1pp | |
| Liquidity | |||||
| Current ratio | 7.3×— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Kestra Medical Technologies, Ltd. Common Stock's profit margins?
- Kestra Medical Technologies, Ltd. Common Stock (KMTS) runs a 48.8% gross margin and a -171.5% operating margin, with a -173.0% net margin.
- Where do Kestra Medical Technologies, Ltd. Common Stock's ratios come from?
- Every ratio is computed from Kestra Medical Technologies, Ltd. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
